Paper Details
- Home
- Paper Details
Original Abstract of the Article :
Among the various available hypolipidemic agents only clofibrate-related substances, d-thyroxine and nicotinic acid are capable of lowering serum lipid values together with a relative or absolute rise of HDL. By that means one atherogenic risk factor is eliminated and compensated by an anti-risk fac...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://pubmed.ncbi.nlm.nih.gov/456970
データ提供：米国国立医学図書館（NLM）
Antilipemic Agents: A Clinical-Pharmacological View
The field of [cardiovascular health] is like a vast and challenging desert, where researchers seek to combat the threat of heart disease. This study explores the landscape of [antilipemic agents], medications used to lower lipid levels in the blood, focusing on their [clinical-pharmacological properties] and [potential benefits] for heart health. The researchers highlight the importance of [raising HDL levels] in addition to lowering LDL levels, as this can further reduce the risk of cardiovascular disease. It's like finding a hidden oasis in the desert, where both water and shade provide protection from the harsh elements.
The Quest for Effective Lipid-Lowering Drugs
The study also notes the importance of [minimizing side effects] associated with antilipemic agents. It's like navigating a desert with treacherous sandstorms and hidden dangers, we must carefully choose our path and avoid potential risks. The research emphasizes the need for [ongoing research] to develop new and improved lipid-lowering drugs that can effectively reduce the risk of cardiovascular disease. This quest is akin to a desert explorer seeking a mythical oasis, where the ultimate goal is to find a solution that can improve human health and well-being.
Navigating the Landscape of Lipid-Lowering Drugs
The findings of this study provide valuable insights into the complex landscape of antilipemic agents. By understanding the different properties and potential side effects of these drugs, healthcare professionals can better guide patients towards the most appropriate treatment options. It's like a map of a desert, guiding us through the terrain and helping us make informed decisions for our health.
Dr.Camel's Conclusion
This study highlights the importance of understanding the nuances of antilipemic agents and their impact on cardiovascular health. It's like a desert oasis offering a variety of resources, each with its own unique properties and potential benefits. By carefully considering our options and consulting with a healthcare professional, we can make informed decisions that can help protect our heart health and well-being.
Date :
- Date Completed 1979-09-17
- Date Revised 2013-11-21
Related Literature
German
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.